Real-Time Genomic Data Pipeline Ingestion for Precision Matching

Manual processes for ingesting lab reports, annotating variants, and cross-referencing trial registries can take 4–6 weeks per cohort. A custom streaming pipeline with automated annotation agents performs this continuously, identifying genotype-matched candidates as soon as sequencing data is available. The operational upside comes from collapsing weeks of data latency into near-real-time matching, directly accelerating time-to-first-patient-in.

Lab data arrives in fragmented formats (VCF, PDF, HL7). Manual curation and entry into screening systems is a high-cost, error-prone bottleneck. A custom workflow automates file ingestion, parsing, and normalization using specialized data-transformation agents, freeing bioinformaticians and clinical staff for higher-value analysis. Savings accrue from reduced FTEs on data wrangling and lower error-driven rework.

Batch-based matching often misses patients or includes poor-fit candidates due to stale data. A real-time pipeline continuously evaluates new genomic data against the latest trial eligibility, using logic agents to apply complex biomarker logic (e.g., variant pathogenicity, allele frequency). This improves the quality of the candidate list, reducing screen-fail rates and increasing the scientific yield per patient screened.

Without a live view of genotype prevalence, feasibility assessments are guesses. This pipeline provides a continuous feed of real-world genomic data, enabling simulation agents to model cohort size for a proposed protocol. Sponsors can de-risk study design and select sites based on actual variant density in their catchment areas, preventing costly under-enrollment and protocol amendments.

Manual processes lack audit trails for data provenance and matching decisions—a regulatory risk. A custom workflow embeds governance by design: each data transformation, annotation, and matching step is logged with rationale. This creates a defensible, reproducible process that scales across dozens of trials and thousands of patients, satisfying IRB and regulatory scrutiny for AI-assisted screening.

A viable build starts with a focused pilot on one biomarker (e.g., NSCLC with EGFR variants). Architecture uses a cloud-native streaming service (e.g., Kafka, Pub/Sub) for ingestion, containerized annotation agents (using tools like SnpEff, VEP), and orchestration via LangGraph or Prefect to manage the matching logic. The pipeline integrates with the EHR via FHIR and the CTMS via API, with human-in-the-loop review gates before site notification.

This agent orchestrates the continuous ingestion of genomic data files (FASTQ, VCF) from lab LIMS, biobank APIs, and cloud storage. It validates file integrity, checks for required metadata (sample ID, sequencing platform, consent flags), and routes invalid files to a quarantine queue for manual review. Built on a framework like Apache Kafka or AWS Kinesis, it ensures data arrives in a structured, time-ordered stream for downstream processing.

A core processing agent that annotates raw variants with clinical significance (using databases like ClinVar, dbSNP) and harmonizes them to a standard genomic coordinate system (e.g., GRCh38). It executes bioinformatics pipelines (e.g., using Snakemake or Nextflow orchestration) to ensure consistent annotation across different lab sources. Output is a normalized, query-ready variant table linked to patient identifiers.

This agent merges the processed genomic data with structured EHR data (diagnoses, medications, lab values) and unstructured clinical narratives (via a separate NLP pipeline). It executes genotype-to-trial matching logic, comparing patient variant profiles against trial protocol biomarker criteria. The matching engine uses a rules-based system (e.g., Drools) or a vector similarity search for complex phenotypic descriptions, generating a ranked list of candidate patients.

A control layer that manages data use agreement (DUA) compliance, logs all data access, and generates an immutable audit trail for regulatory inspection. Before a candidate list is released to a study team, it routes patient profiles through a secure physician review interface (integrated with Epic or Cerner) for final validation. This gateway ensures human oversight, captures rationale for inclusion/exclusion, and maintains HIPAA/GDPR compliance across decentralized data sources.

A monitoring system built on Prometheus/Grafana or Datadog that provides real-time visibility into pipeline performance: ingestion rates, annotation job success/failure, matching latency, and data quality metrics (e.g., variant call rate). It triggers automated alerts for pipeline failures or data drift, enabling proactive maintenance. This dashboard is critical for operational reliability and proving the ROI of the automated workflow to stakeholders.

Practical build considerations: The pipeline is typically deployed as containerized microservices (Docker/Kubernetes) in the sponsor's VPC or a compliant cloud (AWS, Azure). Key integrations include: lab LIMS (via HL7 or REST APIs), EHR systems (via FHIR APIs or intermediary platforms like TriNetX), and clinical trial management systems (CTMS like Veeva Vault). A pilot implementation focuses on 1-2 sequencing labs and a single therapeutic area, with a rollout plan to scale across the portfolio.